Next Article in Journal
Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2− Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies
Next Article in Special Issue
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin
Previous Article in Journal
Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
 
 
Article

Article Versions Notes

Cancers 2021, 13(21), 5394; https://doi.org/10.3390/cancers13215394
Action Date Notes Link
article xml file uploaded 27 October 2021 15:27 CEST Original file -
article xml uploaded. 27 October 2021 15:27 CEST Update -
article pdf uploaded. 27 October 2021 15:27 CEST Version of Record https://www.mdpi.com/2072-6694/13/21/5394/pdf-vor
article supplementary file uploaded. 27 October 2021 15:27 CEST - https://www.mdpi.com/2072-6694/13/21/5394#supplementary
article html file updated 27 October 2021 15:29 CEST Original file -
article xml file uploaded 28 October 2021 10:10 CEST Update -
article xml uploaded. 28 October 2021 10:10 CEST Update https://www.mdpi.com/2072-6694/13/21/5394/xml
article pdf uploaded. 28 October 2021 10:10 CEST Updated version of record https://www.mdpi.com/2072-6694/13/21/5394/pdf
article html file updated 28 October 2021 10:20 CEST Update -
article html file updated 30 July 2022 13:25 CEST Update https://www.mdpi.com/2072-6694/13/21/5394/html
Back to TopTop